×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
PACB – pacific biosciences of california, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
PACB
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/19
07:06 pm
pacb
Pacific Biosciences of California, Inc. (PACB): Among the Best Genomics Stocks to Buy Right Now [Yahoo! Finance]
Neutral
Report
Pacific Biosciences of California, Inc. (PACB): Among the Best Genomics Stocks to Buy Right Now [Yahoo! Finance]
11/14
08:07 am
pacb
Pacific Biosciences of California, Inc. (NASDAQ: PACB) was upgraded by analysts at UBS Group AG to a "hold" rating.
Medium
Report
Pacific Biosciences of California, Inc. (NASDAQ: PACB) was upgraded by analysts at UBS Group AG to a "hold" rating.
11/13
12:08 am
pacb
Pacific Biosciences of California, Inc. (NASDAQ: PACB) was upgraded by analysts at StockNews.com to a "sell" rating.
High
Report
Pacific Biosciences of California, Inc. (NASDAQ: PACB) was upgraded by analysts at StockNews.com to a "sell" rating.
11/11
02:01 pm
pacb
Pacific Biosciences of California, Inc. (NASDAQ: PACB) had its price target lowered by analysts at Scotiabank from $7.00 to $6.00. They now have a "sector outperform" rating on the stock.
Medium
Report
Pacific Biosciences of California, Inc. (NASDAQ: PACB) had its price target lowered by analysts at Scotiabank from $7.00 to $6.00. They now have a "sector outperform" rating on the stock.
11/11
10:15 am
pacb
Pacific Biosciences of California, Inc. (NASDAQ: PACB) was downgraded by analysts at UBS Group AG from a "buy" rating to a "neutral" rating.
High
Report
Pacific Biosciences of California, Inc. (NASDAQ: PACB) was downgraded by analysts at UBS Group AG from a "buy" rating to a "neutral" rating.
11/11
08:09 am
pacb
Pacific Biosciences of California, Inc. (NASDAQ: PACB) had its price target raised by analysts at Piper Sandler from $2.00 to $2.50. They now have a "neutral" rating on the stock.
Medium
Report
Pacific Biosciences of California, Inc. (NASDAQ: PACB) had its price target raised by analysts at Piper Sandler from $2.00 to $2.50. They now have a "neutral" rating on the stock.
11/9
08:42 am
pacb
Earnings Update: Pacific Biosciences of California, Inc. (NASDAQ:PACB) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts [Yahoo! Finance]
Medium
Report
Earnings Update: Pacific Biosciences of California, Inc. (NASDAQ:PACB) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts [Yahoo! Finance]
11/8
04:05 pm
pacb
PacBio to Present at Upcoming Investor Conferences
Medium
Report
PacBio to Present at Upcoming Investor Conferences
Date
Time
Symbol
Company Name
Action
%Chg
11/7/2024
04:05 pm
pacb
pacific biosciences of california, inc.
BEAT
Report
-6.5%
pacific biosciences of california, inc.
8/7/2024
04:05 pm
pacb
pacific biosciences of california, inc.
BEAT
Report
11.3%
pacific biosciences of california, inc.
5/9/2024
04:05 pm
pacb
pacific biosciences of california, inc.
IN-LINE
Report
3.5%
pacific biosciences of california, inc.
2/15/2024
04:05 pm
pacb
pacific biosciences of california, inc.
BEAT
Report
-14.0%
pacific biosciences of california, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/14
05:53 pm
pacb
Form SC 13G PACIFIC BIOSCIENCES OF Filed by: EDMOND DE ROTHSCHILD ASSET MANAGEMENT (FRANCE)
High
Report
Form SC 13G PACIFIC BIOSCIENCES OF Filed by: EDMOND DE ROTHSCHILD ASSET MANAGEMENT (FRANCE)
11/14
05:48 pm
pacb
Form SC 13G/A PACIFIC BIOSCIENCES OF Filed by: MADRONE CAPITAL PARTNERS, LLC
High
Report
Form SC 13G/A PACIFIC BIOSCIENCES OF Filed by: MADRONE CAPITAL PARTNERS, LLC
11/12
04:44 pm
pacb
Form SC 13G/A PACIFIC BIOSCIENCES OF Filed by: VANGUARD GROUP INC
High
Report
Form SC 13G/A PACIFIC BIOSCIENCES OF Filed by: VANGUARD GROUP INC
11/12
09:28 am
pacb
Form 8-K PACIFIC BIOSCIENCES OF For: Nov 11
Medium
Report
Form 8-K PACIFIC BIOSCIENCES OF For: Nov 11
11/12
09:19 am
pacb
Form 10-Q PACIFIC BIOSCIENCES OF For: Sep 30
Medium
Report
Form 10-Q PACIFIC BIOSCIENCES OF For: Sep 30
11/8
04:19 pm
pacb
Form SC 13G PACIFIC BIOSCIENCES OF Filed by: MILLENNIUM MANAGEMENT LLC
Medium
Report
Form SC 13G PACIFIC BIOSCIENCES OF Filed by: MILLENNIUM MANAGEMENT LLC
11/7
04:06 pm
pacb
Form 8-K PACIFIC BIOSCIENCES OF For: Nov 05
Medium
Report
Form 8-K PACIFIC BIOSCIENCES OF For: Nov 05
11/7
04:03 pm
pacb
Form 8-K PACIFIC BIOSCIENCES OF For: Nov 07
Medium
Report
Form 8-K PACIFIC BIOSCIENCES OF For: Nov 07
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/18
Pacific Biosciences down 19% after patent ruling [Seeking Alpha]
14.8%
3/16 Form 4 PACIFIC BIOSCIENCES OF For: Mar 16 Filed by: HENRY CHRISTIAN O 13.3%
3/24 Pacific Biosciences of California (NASDAQ: PACB) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. 8.5%
4/28 Form DEF 14A PACIFIC BIOSCIENCES OF For: Apr 28 7.9%
3/5 Christian Henry Appointed Chairman of Pacific Biosciences’ Board of Directors 6.5%
4/8 Pacific Biosciences Powers SARS-CoV-2 Research at Commercial, Academic and Government Labs 5.3%
10/15 Pacific Biosciences of California (NASDAQ: PACB) was upgraded by analysts at Piper Jaffray Companies from a "neutral" rating to an "overweight" rating. 5.1%
6/18 Form 8-K PACIFIC BIOSCIENCES OF For: Jun 18 4.9%
2/27 Pacific Biosciences of California (NASDAQ: PACB) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. 3.5%
4/2 Form 3 PACIFIC BIOSCIENCES OF For: Apr 01 Filed by: Zaccarin Denis 3.4%
3/16 Form 4 PACIFIC BIOSCIENCES OF For: Mar 16 Filed by: HENRY CHRISTIAN O 13.3%
3/24 Pacific Biosciences of California (NASDAQ: PACB) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. 8.5%
4/28 Form DEF 14A PACIFIC BIOSCIENCES OF For: Apr 28 7.9%
3/5 Christian Henry Appointed Chairman of Pacific Biosciences’ Board of Directors 6.5%
4/8 Pacific Biosciences Powers SARS-CoV-2 Research at Commercial, Academic and Government Labs 5.3%
10/15 Pacific Biosciences of California (NASDAQ: PACB) was upgraded by analysts at Piper Jaffray Companies from a "neutral" rating to an "overweight" rating. 5.1%
6/18 Form 8-K PACIFIC BIOSCIENCES OF For: Jun 18 4.9%
2/27 Pacific Biosciences of California (NASDAQ: PACB) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. 3.5%
4/2 Form 3 PACIFIC BIOSCIENCES OF For: Apr 01 Filed by: Zaccarin Denis 3.4%
TOP News Decliners
2/6
Pacific Biosciences of California, Inc. (PACB) CEO Mike Hunkapiller on Q4 2019 Results - Earnings Call Transcript [Seeking Alpha]
-11.6%
2/10 Form SC 13G/A PACIFIC BIOSCIENCES OF Filed by: BlackRock Inc. -9.9%
2/25 Form 4 PACIFIC BIOSCIENCES OF For: Feb 19 Filed by: BARNES SUSAN K -9.9%
2/20 Form 4 PACIFIC BIOSCIENCES OF For: Feb 18 Filed by: BARNES SUSAN K -6.5%
8/13 Pacific Biosciences of California (NASDAQ: PACB) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -5.3%
2/24 Form 4 PACIFIC BIOSCIENCES OF For: Feb 20 Filed by: Hunkapiller Michael -5.1%
12/16 Pacific Biosciences of California (NASDAQ: PACB) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -3.9%
11/7 Q3/2019 9/30/2019 EPS -0.190 ZacksConsensus -0.140 ActVsEst (0.050) - Miss -3.7%
11/4 Pacific Biosciences of California (NASDAQ: PACB) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating. -2.4%
9/26 Form 8-K PACIFIC BIOSCIENCES OF For: Sep 25 -2.3%
2/10 Form SC 13G/A PACIFIC BIOSCIENCES OF Filed by: BlackRock Inc. -9.9%
2/25 Form 4 PACIFIC BIOSCIENCES OF For: Feb 19 Filed by: BARNES SUSAN K -9.9%
2/20 Form 4 PACIFIC BIOSCIENCES OF For: Feb 18 Filed by: BARNES SUSAN K -6.5%
8/13 Pacific Biosciences of California (NASDAQ: PACB) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -5.3%
2/24 Form 4 PACIFIC BIOSCIENCES OF For: Feb 20 Filed by: Hunkapiller Michael -5.1%
12/16 Pacific Biosciences of California (NASDAQ: PACB) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -3.9%
11/7 Q3/2019 9/30/2019 EPS -0.190 ZacksConsensus -0.140 ActVsEst (0.050) - Miss -3.7%
11/4 Pacific Biosciences of California (NASDAQ: PACB) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating. -2.4%
9/26 Form 8-K PACIFIC BIOSCIENCES OF For: Sep 25 -2.3%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: